Skip to main content

Table 1 Comparison of clinical characteristics between patients with and without carotid atherosclerotic plaque

From: The association between serum adropin and carotid atherosclerosis in patients with type 2 diabetes mellitus: a cross‑sectional study

Characteristic

Without carotid plaque

With carotid plaque

p-value

(n = 223)

(n = 280)

Demographic characteristics

 Age (years)

51.6 ± 9.8

61.5 ± 10.1

 < 0.001

 Male

133 (59.6)

164 (58.6)

0.880

 WC (cm)

88.6 ± 9.2

89.9 ± 10.8

0.033

 BMI (kg/m2)

23.9 ± 3.1

24.8 ± 3.6

0.004

Medical history and Clinical condition

 Smoking history

70 (31.4)

103 (36.8)

0.242

 Hypertension

75 (33.6)

131 (46.8)

0.004

 SBP (mmHg)

134.4 ± 18.5

139.3 ± 19.3

0.004

 DBP (mmHg)

83.9 ± 12.2

80.9 ± 12.2

0.006

 Duration of diabetes (years)

4 (0, 10)

8 (3, 11)

 < 0.001

 DR

23 (13.9)

59 (27.7)

0.005

 DPN

72 (55.0)

103 (57.2)

0.752

 DN

15 (9.3)

51 (24.4)

 < 0.001

 Stroke

5 (2.2)

17 (6.1)

0.062

 NAFLD

116 (58.0)

117 (50.2)

0.128

Laboratory examination

 Adropin (ng/ml)

20.5 ± 4.0

20.6 ± 3.7

0.763

 FBG (mmol/L)

9.2 ± 3.4

9.1 ± 3.5

0.852

 2hPBG (mmol/L)

13.1 ± 4.8

13.2 ± 5.1

0.751

 HbA1c (%)

10.1 ± 2.5

10.7 ± 2.7

0.056

 HOMA-IR

13.8 (7.6, 27.7)

17.9 (8.7, 32.3)

0.023

 TG (mmol/L)

2.2 ± 1.8

1.9 ± 1.5

0.057

 TC (mmol/L)

5.0 ± 1.2

4.9 ± 1.2

0.192

 HDL-C (mmol/L)

1.2 ± 0.4

1.3 ± 0.5

0.167

 LDL-C (mmol/L)

3.2 ± 1.0

3.1 ± 1.1

0.305

 eGFR (ml/min/1.73 m2)

124.0 ± 38.1

106.8 ± 36.0

 < 0.001

 UA (μmol/L)

344.8 ± 92.4

345.0 ± 91.3

0.981

 hs-CRP (mg/L)

1.2 (0.6, 2.3)

1.4 (0.7, 2.9)

0.090

 HCY (μmol/L)

10.6 ± 3.3

11.4 ± 3.8

0.018

Administered drugs

 Insulin

36 (16.1)

58 (20.7)

0.234

 OADs

123 (55.4)

173 (62.5)

0.133

 Statins

6 (2.7)

17 (6.1)

0.112

  1. WC waist circumference, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, DR diabetic retinopathy, DPN diabetic peripheral neuropathy, DN diabetic nephropathy, CAD coronary artery disease, NAFLD Nonalcoholic fatty liver disease, FBG Fasting blood glucose, 2 h PBG 2 h postprandial blood glucose, HbA1c glycosylated hemoglobin, HOMA-IR homeostatic model assessment-insulin resistance, TG triglyceride, TC total cholesterol, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, eGFR estimated glomerular filtrationrate, UA uric acid, hs-CRP hypersensitive C-reactive protein, HCY homocysteine, OADs oral antidiabetic drugs